Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the immediate impact on exports is likely to be limited, the proposed escalation to 100% and eventually 200% tariffs could significantly alter the economics of supplying generic medicines to the US if manufacturers do not establish a stronger local production footprint.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/KYmzZXp
via IFTTT